Rhythm Biosciences Limited [ASX:RHY] share price and news 2022

Company Description

Rhythm Biosciences Limited (RHY) is involved in developing and commercialising Australian medical diagnostics technology for sale in domestic and international markets. Rhythm Biosciences, ColoSTAT is the first proposed product-in-development, intended as a test for the accurate and early detection of colorectal cancer.

Rhythm Biosciences Limited belongs to Health Care sector and under industry of Health Care Services. You can get more information about this company via their website: http://www.rhythmbio.com.

This a small cap company with market cap of 306 millions.

Compared to Market and Sector

The following table compares the company to Market and Sector based on Earning, Price/Earning ratio(P/E), Price/Book ratio (P/B) and PE growth.

Company PE is less than both sector and market. while Company PB is greater than both sector and market. On the other hand, Company Earning is less than both sector and market.

Earnings PE PB PE growth
Company 0 0 95 0
Market 0.85 22.3 1.99 0.84
Sector 1.29 25.9 4.23 1.53

Dividend Growth Chart

The following chart shows you how rhy dividend grows in the recent years.

No data